US 7256171
Use of core 2 G1cNAc transferase inhibitors in treating inflammation
granted A61KA61K31/7088
Quick answer
US patent 7256171 (Use of core 2 G1cNAc transferase inhibitors in treating inflammation) held by The Regents of the University of California expires Mon Aug 09 2027 00:00:00 GMT+0000 (Coordinated Universal Time). Status: granted.
Key facts
- Applicant
- The Regents of the University of California
- Grant date
- Tue Aug 14 2007 00:00:00 GMT+0000 (Coordinated Universal Time)
- Expiration
- Mon Aug 09 2027 00:00:00 GMT+0000 (Coordinated Universal Time)
- Claims
- 12
- CPC classes
- A61K, A61K31/7088